arrow
B

Bertrand Dubois

centre de recherche en cancerologie de lyon
H指数:42
被引数:9,333

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Compartmentalized cytotoxic CD4+ T cell responses in anti-Yo paraneoplastic cerebellar degeneration

抗Yo副肿瘤小脑变病中隔化的CD4+ T细胞毒反应

2026-09-010
OAAI
Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trial

新辅助免疫检查点阻断在宫颈鳞癌患者化疗放疗前的应用(GINECO window-of-opportunity COLIBRI研究):一项II期临床试验

2026-01-050
OAAI
Immune landscape and TAM density in endometrial cancer: implications for immune checkpoint inhibitors efficacy

子宫内膜癌的免疫景观和肿瘤相关巨噬细胞密度:对免疫检查点抑制剂疗效的启示

2025-08-080
OA
Tumor–stroma proportion on primary tumor as a prognostic biomarker in advanced ovarian cancer patients receiving chemo-immunotherapy as first-line therapy: analyses from the NeoPembrOV/GINECO phase II randomized trial

原发性肿瘤中肿瘤-基质比例作为接受化疗-免疫疗法作为一线治疗的晚期卵巢癌患者的预后生物标志物:NeoPembrOV/GINECO II期随机试验的分析

2025-06-010
OA
Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma
2024-07-162
OAAI
Modulation of blood T cell polyfunctionality and HVEM/BTLA expression are critical determinants of clinical outcome in anti-PD1-treated metastatic melanoma patients
2024-06-260
OA
The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers
2024-01-2410
PRE
Different Genetic Signatures of Small-Cell Lung Cancer Characterize Anti-GABABR and Anti-Hu Paraneoplastic Neurological Syndromes
2023-09-188
PRE
Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study
2023-04-013
OAAI
Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration
2022-09-0112
OAAI
ZEB1 transcription factor promotes immune escape in melanoma

ZEB1转录因子促进黑色素瘤免疫逃逸

2022-03-1442
OAAI
Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration
2018-01-0370
PREAI